GHK-Cu
CU50
Lyophilized peptide for use under a licensed healthcare provider. Choose single ampule/vial or box of 10. Sourced via Ares Technology Limited (Hong Kong) / Healthtide Biotech manufacturing list dated 7 October 2026. Specification: 50 mg × 10 vials.
- • Prescription / clinician-supervised pathway
- • Same LIRAVEXIN cart and checkout as pen packages
- • Not medical advice — individual suitability is determined by your clinician
Clinical reference (clinician-supervised)
Topical cosmetic science (firmness, appearance of photodamage) and investigational regenerative discussions. Injectable wellness use is not an FDA-approved indication.
No injectable FDA label for systemic repair. Topical cosmetic concentrations vary by formulation. Injectable clinic regimens are non-standardized—clinician decides; often no reliable systemic human dose.
Topicals per product; injectables not established.
Primarily topical in evidence-backed cosmetic use; SC discussed off-label/investigational.
Typical clinical / literature ranges under clinician supervision — not a prescription and not a DIY dosing guide. Individual dosing is determined solely by the treating clinician.
Liravexin USD for this pack (wholesale comparison · source × 3). Item is added to your shared cart for checkout coordination with your clinician pathway.
Or continue to checkout →